Prospective follow-up of epstein-barr virus load in adult kidney transplant recipients by semiquantitative polymerase chain reaction in blood and saliva samples

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 12, 2001, Pages 892-895

  Frias C ^a   Lauzurica, R ^a   Bayes B ^a   Ausina, V ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS MONONUCLEOSIS; KIDNEY GRAFT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; SALIVA ANALYSIS; VIRUS LOAD;

ADULT; AGED; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SALIVA; VIRAL LOAD; VIREMIA;

EID: 0035710919     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-001-0652-6     Document Type: Article

References (14)

1. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center
2. Detection of Epstein-Barr virus by the polymerase chain reaction
3. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease
4. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: Relationship to immunosuppressive therapy, serologic responses, and the risk of post-transplant lymphoproliferative disorder
5. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas
6. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients
7. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease
8. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease
9. Frequent monitoring of Epstein-Barr virus DNA in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
10. Prospective study of Epstein-Barr virus chronic infection in renal transplant recipients
11. Quantitation of Epstein-Barr virus DNA in the blood of adult liver transplant recipients
12. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder
13. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders
14. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation